Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4081751
Reference Type
Book/Book Chapter
Title
Chapter 13: Endocrine Glands
Author(s)
Greaves, P
Year
2012
Publisher
Elsevier Science
Location
Amsterdam, Netherlands
Book Title
Histopathology of preclinical toxicity studies: Interpretation and relevance in drug safety evaluation
Page Numbers
725–797
Language
English
DOI
10.1016/B978-0-444-53856-7.00013-0
Relationship(s)
is a chapter of
2919080
Histopathology of preclinical toxicity studies: Interpretation and relevance in drug safety evaluation
Abstract
This chapter provides an overview of species differences in the anatomy and physiology of the endocrine system among rodents, dogs and primates, emphasizing the differences in control systems that may influence the interpretation of drug-induced changes and their relevance for people. It describes and discusses the human relevance of drug-induced changes in the pituitary gland, adrenal cortex, adrenal medulla, follicular and C cells of the thyroid and parathyroid glands.
Notable changes in endocrine tissues in toxicity studies are various forms of atrophy, hypertrophy, hyperplasia and neoplasia as a result of perturbation in endocrine balance when high doses of potent therapies are administered. The difficulties in the histological distinction between hyperplasia, benign and malignant neoplasia in endocrine tissues is discussed.
This chapter reviews the likely relevance of such changes in the evaluation of the safety of drugs, particularly in long-term high dose studies in rodents.
Edition
4th
ISBN
9780444538567
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity